| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HYPERFINE Aktie jetzt für 0€ handeln | |||||
| Mi | Hyperfine targets $20M-$22M 2026 revenue while maintaining 50%-55% gross margin | 2 | Seeking Alpha | ||
| Di | Hyperfine Q1 2026 Earnings Call Transcript | 1 | Benzinga.com | ||
| Di | Hyperfine GAAP EPS of -$0.09 in-line, revenue of $3.90M beats by $0.37M | 1 | Seeking Alpha | ||
| Di | Hyperfine, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Di | Hyperfine, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.04. | This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday | 3 | Benzinga.com | ||
| 29.04. | BTIG initiates Hyperfine stock with buy rating on MRI technology | 5 | Investing.com | ||
| 20.04. | HII Launches HYPR Program with Path Robotics and GrayMatter Robotics to Accelerate Production at Scale | 2 | GlobeNewswire (USA) | ||
| 09.04. | Hyperfine, Inc.: Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop System and Latest Advancement in Optive AI Software | 392 | Business Wire | This milestone unlocks Hyperfine's most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality... ► Artikel lesen | |
| 25.03. | Hyperfine: $40 Million Loan Facility Secured To Expand Portable MRI Commercialization | 2 | pulse2.com | ||
| 23.03. | Hyperfine secures $40M loan facility | - | MassDevice | ||
| 23.03. | Horizon Technology Finance finanziert Hyperfine mit 40 Millionen US-Dollar | 9 | Investing.com Deutsch | ||
| 19.03. | Lake Street raises Hyperfine stock price target on revenue growth outlook | 2 | Investing.com | ||
| 19.03. | Hyperfine outlines 55% revenue growth target for 2026 while expanding Swoop MRI adoption across hospitals and neurology offices | 2 | Seeking Alpha | ||
| 18.03. | Mitschrift des Earnings Call: Hyperfine übertrifft im 4. Quartal 2025 die Erwartungen, Aktie legt zu | 13 | Investing.com Deutsch | ||
| 18.03. | Hyperfine, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 18.03. | Hyperfine, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 18.03. | Hyperfine GAAP EPS of -$0.06 beats by $0.02, revenue of $5.29M misses by $0.01M | 1 | Seeking Alpha | ||
| 18.03. | Hyperfine, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.03. | LIONESS MEDTECH AB: Hyperfine Swoop Portable MRI Presented by Lioness Medtech at Akutveckan 2026 | 3 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 369,40 | +0,46 % | INTUITIVE SURGICAL INC in stabiler Marktphase | ||
| MEDTRONIC | 65,06 | -0,58 % | Medtronic (MDT) Stock Drops Despite Market Gains: Important Facts to Note | ||
| THERMO FISHER | 381,30 | -2,53 % | Jim Cramer on Thermo Fisher: "I Think You Can Buy It at This Level" | ||
| STRATEC | 17,360 | +1,05 % | STRATEC startet verhalten ins Jahr 2026 - deutliche Belebung im zweiten Halbjahr erwartet | STRATEC ist erwartungsgemäß verhalten in das Geschäftsjahr 2026 gestartet. Belastet von einem weiterhin schwierigen Marktumfeld sowie einem schwächeren Produktmix gingen Umsatz und Ergebnis im ersten... ► Artikel lesen | |
| RHOEN-KLINIKUM | 12,600 | +2,44 % | EQS-News: RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG mit stabiler Entwicklung im ersten Quartal 2026 | EQS-News: RHÖN-KLINIKUM Aktiengesellschaft
/ Schlagwort(e): Quartalsergebnis/Sonstiges
RHÖN-KLINIKUM AG mit stabiler Entwicklung im ersten Quartal 2026
07.05.2026 / 20:42... ► Artikel lesen | |
| HIMS & HERS HEALTH | 20,580 | -3,47 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 59,26 | -0,50 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| BECTON DICKINSON | 122,85 | -2,27 % | Bactiguard Holding AB: Bactiguard and BD strengthen global partnership expanding access to Foley catheters designed to reduce infection risk for patients worldwide | Bactiguard Holding AB (publ) today announces an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company), a leading global medical technology company, through... ► Artikel lesen | |
| FAMICORD | 4,000 | 0,00 % | FAMICORD AG - Schwäche als Prüfstein der Substanz | ||
| GERATHERM MEDICAL | 2,750 | 0,00 % | Geratherm Medical wechselt vom Börsensegment Scale in den Open Market | Die Geratherm Medical AG beendet zum 27. April 2026 die Einbeziehung ihrer Aktien in das Börsensegment Scale der Frankfurter Wertpapierbörse und wechselt ins Basic Board am Open Market. Die Börsennotierung... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 45,380 | -1,60 % | BOSTON SCIENTIFIC CORP - S-8, Securities to be offered to employees in employee benefit plans | ||
| SYNLAB | 12,710 | 0,00 % | Konkurrent von Synlab: Milliardendeal in der Laborbranche bahnt sich an | ||
| PAUL HARTMANN | 206,00 | 0,00 % | Dividendenbekanntmachungen (30.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| RESMED | 173,00 | -0,37 % | Should you buy ResMed shares at their 52-week low? | ||
| MCKESSON | 629,00 | +0,51 % | McKesson Corp. Reveals Increase In Q4 Profit | WASHINGTON (dpa-AFX) - McKesson Corp. (MCK) reported earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line totaled $1.68 billion, or $13.78... ► Artikel lesen |